Krystal Biotech, Inc. (NASDAQ:KRYS) Q3 2023 Earnings Call Transcript November 6, 2023
Krystal Biotech, Inc. beats earnings expectations. Reported EPS is $-0.69, expectations were $-1.1.
Operator: Thank you for standing by and welcome to the Krystal Biotech Third Quarter 2023 Earnings Conference Call. As a reminder today’s conference call is being recorded. I would now like to hand the conference over to your host Meg Dodge, Head of Investor Relations and Corporate Communications. Please...
